These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 11250942
1. Glucocorticoid receptor-interacting protein-1 and receptor-associated coactivator-3 differentially interact with the vitamin D receptor (VDR) and regulate VDR-retinoid X receptor transcriptional cross-talk. Issa LL, Leong GM, Barry JB, Sutherland RL, Eisman JA. Endocrinology; 2001 Apr; 142(4):1606-15. PubMed ID: 11250942 [Abstract] [Full Text] [Related]
2. Vitamin D analogue-specific recruitment of vitamin D receptor coactivators. Issa LL, Leong GM, Sutherland RL, Eisman JA. J Bone Miner Res; 2002 May; 17(5):879-90. PubMed ID: 12009019 [Abstract] [Full Text] [Related]
3. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation. Raval-Pandya M, Freedman LP, Li H, Christakos S. Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705 [Abstract] [Full Text] [Related]
4. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast. Kephart DD, Walfish PG, DeLuca H, Butt TR. Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985 [Abstract] [Full Text] [Related]
5. The vitamin D hormone and its nuclear receptor: molecular actions and disease states. Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK. J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138 [Abstract] [Full Text] [Related]
6. Antagonistic effects of transforming growth factor-beta on vitamin D3 enhancement of osteocalcin and osteopontin transcription: reduced interactions of vitamin D receptor/retinoid X receptor complexes with vitamin E response elements. Staal A, Van Wijnen AJ, Desai RK, Pols HA, Birkenhäger JC, Deluca HF, Denhardt DT, Stein JL, Van Leeuwen JP, Stein GS, Lian JB. Endocrinology; 1996 May; 137(5):2001-11. PubMed ID: 8612541 [Abstract] [Full Text] [Related]
7. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation. Bettoun DJ, Burris TP, Houck KA, Buck DW, Stayrook KR, Khalifa B, Lu J, Chin WW, Nagpal S. Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883 [Abstract] [Full Text] [Related]
8. Synergistic activation of the prolactin promoter by vitamin D receptor and GHF-1: role of the coactivators, CREB-binding protein and steroid hormone receptor coactivator-1 (SRC-1). Castillo AI, Jimenez-Lara AM, Tolon RM, Aranda A. Mol Endocrinol; 1999 Jul; 13(7):1141-54. PubMed ID: 10406465 [Abstract] [Full Text] [Related]
9. GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors. Hong H, Kohli K, Garabedian MJ, Stallcup MR. Mol Cell Biol; 1997 May; 17(5):2735-44. PubMed ID: 9111344 [Abstract] [Full Text] [Related]
10. Coactivator-vitamin D receptor interactions mediate inhibition of the atrial natriuretic peptide promoter. Chen S, Cui J, Nakamura K, Ribeiro RC, West BL, Gardner DG. J Biol Chem; 2000 May 19; 275(20):15039-48. PubMed ID: 10809746 [Abstract] [Full Text] [Related]
11. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes. Staal A, van Wijnen AJ, Birkenhäger JC, Pols HA, Prahl J, DeLuca H, Gaub MP, Lian JB, Stein GS, van Leeuwen JP, Stein JL. Mol Endocrinol; 1996 Nov 19; 10(11):1444-56. PubMed ID: 8923469 [Abstract] [Full Text] [Related]
12. Regulation of ligand-induced heterodimerization and coactivator interaction by the activation function-2 domain of the vitamin D receptor. Liu YY, Nguyen C, Peleg S. Mol Endocrinol; 2000 Nov 19; 14(11):1776-87. PubMed ID: 11075811 [Abstract] [Full Text] [Related]
13. Vitamin D represses retinoic acid-dependent transactivation of the retinoic acid receptor-beta2 promoter: the AF-2 domain of the vitamin D receptor is required for transrepression. Jiménez-Lara AM, Aranda A. Endocrinology; 1999 Jun 19; 140(6):2898-907. PubMed ID: 10342883 [Abstract] [Full Text] [Related]
14. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators. Herdick M, Carlberg C. J Mol Biol; 2000 Dec 15; 304(5):793-801. PubMed ID: 11124027 [Abstract] [Full Text] [Related]
15. Differential mechanisms of nuclear receptor regulation by receptor-associated coactivator 3. Leo C, Li H, Chen JD. J Biol Chem; 2000 Feb 25; 275(8):5976-82. PubMed ID: 10681591 [Abstract] [Full Text] [Related]
16. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. Matkovits T, Christakos S. Mol Endocrinol; 1995 Feb 25; 9(2):232-42. PubMed ID: 7776973 [Abstract] [Full Text] [Related]
18. Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues. Barry JB, Leong GM, Church WB, Issa LL, Eisman JA, Gardiner EM. J Biol Chem; 2003 Mar 07; 278(10):8224-8. PubMed ID: 12529369 [Abstract] [Full Text] [Related]
19. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators. Tagami T, Lutz WH, Kumar R, Jameson JL. Biochem Biophys Res Commun; 1998 Dec 18; 253(2):358-63. PubMed ID: 9878542 [Abstract] [Full Text] [Related]
20. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor. Thompson PD, Hsieh JC, Whitfield GK, Haussler CA, Jurutka PW, Galligan MA, Tillman JB, Spindler SR, Haussler MR. J Cell Biochem; 1999 Dec 01; 75(3):462-80. PubMed ID: 10536369 [Abstract] [Full Text] [Related] Page: [Next] [New Search]